AAO 2023: New Modes of Treatments and New Directions for Diabetic Macular Edema

Sunir J. Garg, MD

October 27, 2023

Sunir J. Garg, MD, surveys several key topics to be presented at the American Academy of Ophthalmology (AAO) 2023 meeting, from new modes of treatment to genetic applications to anti–vascular endothelial growth factor therapy, which is an enhancement that offers more long-lasting forms of this treatment.

Another important discussion Dr Garg anticipates involves the protocols surrounding clinical trials, with new emphasis on the selection process so that study populations more accurately reflect the general population, an initiative intended to improve both the development of new treatments and their general efficacy.

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: AAO 2023: New Modes of Treatments and New Directions for Diabetic Macular Edema - Medscape - Oct 27, 2023.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.